Actinic Keratosis: Current Understanding of Pathophysiology and Therapeutic Targets

JDD Multimedia

Featuring Brian Berman, MD, PhD

Join JDD for Part One of this two-part webinar series on “Advancing the Understanding of Actinic Keratosis: New Treatment Options and Strategies.” In this continuing education activity, faculty will explore the pathophysiology and differential diagnosis of actinic keratosis. Dr. Berman will review understanding of therapeutic targets of AK treatment approaches.

Upon completion of this enduring, internet-based webinar, participants should be able to:

Review current understanding of the pathophysiology and differential diagnosis of actinic keratosis
Discuss therapeutic targets of actinic keratosis treatment strategies

Faculty

Brian Berman, MD, PhD
Emeritus Professor of Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine, Miami, FL
Co-Director, Center for Clinical and Cosmetic Research, Miami Beach, Florida

What’s New in Topical Treatment for Actinic Keratosis

Luciana Halliday Nofal | CME Activities, JDD Webinars | No Comments

In this one-hour CME webinar, participants will learn the latest information on new topical therapeutic considerations for actinic keratosis, including the recently approved SrC kinase inhibitor. Upon completion of this…

Facial Skin Tightening With Microfocused Ultrasound and Dermal Fillers: Considerations for Patient Selection and Outcomes

Lindsay OConnor | Aesthetics, CME Activities, Featured Articles | No Comments

Earn 1.0 CME Credit: Human facial aging is a gradual and ongoing process involving various factors including photodamage, skin laxity, volume loss of subcutaneous tissue, and bony resorption.1 CME CreditHuman…

The Science of Sun Protection

courtney cruickshank | CME Activities, Dermatology Podcast Archives | No Comments

Episode 1 of a 2-Part Series: "Sun Protection: A Review of Current Interventions and Barriers to Changing Patient Attitude and Behavior" Photoprotection works, plain and simple. Yet all too often…